These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 26550113

  • 1. IL-6/STAT3/SOCS3 signaling pathway playing a regulatory role in ulcerative colitis carcinogenesis.
    Chen YY, Ma ZB, Xu HY, Shi LJ, Li DY, Sun LY, Yin XH, Sang GY, Xu D, Tang YH, Wang X, Li P, Wu F, Zhou J.
    Int J Clin Exp Med; 2015; 8(8):12009-17. PubMed ID: 26550113
    [Abstract] [Full Text] [Related]

  • 2. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude CJ.
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [Abstract] [Full Text] [Related]

  • 3. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
    Xu AT, Li Y, Zhao D, Shen J, Xu XT, Qiao YQ, Zhu MM, Wang TR, Cui Y, Ai LY, Ran ZH.
    Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
    [Abstract] [Full Text] [Related]

  • 4. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.
    Yu LZ, Wang HY, Yang SP, Yuan ZP, Xu FY, Sun C, Shi RH.
    World J Gastroenterol; 2013 May 07; 19(17):2638-49. PubMed ID: 23674871
    [Abstract] [Full Text] [Related]

  • 5. IL-9 promotes the pathogenesis of ulcerative colitis through STAT3/SOCS3 signaling.
    Tian L, Li Y, Zhang J, Chang R, Li J, Huo L.
    Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30369485
    [Abstract] [Full Text] [Related]

  • 6. STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.
    Li Y, Deuring J, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ.
    Mol Med; 2012 Dec 20; 18(1):1412-9. PubMed ID: 23154639
    [Abstract] [Full Text] [Related]

  • 7. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota.
    Wang C, Li W, Wang H, Ma Y, Zhao X, Zhang X, Yang H, Qian J, Li J.
    BMC Microbiol; 2019 Nov 06; 19(1):246. PubMed ID: 31694526
    [Abstract] [Full Text] [Related]

  • 8. Qing Hua Chang Yin inhibits the LPS-induced activation of the IL-6/STAT3 signaling pathway in human intestinal Caco-2 cells.
    Ke X, Hu G, Fang W, Chen J, Zhang X, Yang C, Peng J, Chen Y, Sferra TJ.
    Int J Mol Med; 2015 Apr 06; 35(4):1133-7. PubMed ID: 25633437
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats.
    Zhu L, Gu P, Shen H.
    Int Immunopharmacol; 2019 Mar 06; 68():242-251. PubMed ID: 30743078
    [Abstract] [Full Text] [Related]

  • 10. Nicotine protects against DSS colitis through regulating microRNA-124 and STAT3.
    Qin Z, Wan JJ, Sun Y, Wu T, Wang PY, Du P, Su DF, Yang Y, Liu X.
    J Mol Med (Berl); 2017 Feb 06; 95(2):221-233. PubMed ID: 27709266
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.
    Li Y, Deuring J, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ.
    Carcinogenesis; 2012 Oct 06; 33(10):1889-96. PubMed ID: 22739025
    [Abstract] [Full Text] [Related]

  • 13. Gingko biloba extract (Ginaton) ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in mice via reducing IL-6/STAT3 and IL-23/IL-17.
    Sun Y, Lin LJ, Lin Y, Sang LX, Jiang M, Zheng CQ.
    Int J Clin Exp Med; 2015 Oct 06; 8(10):17235-47. PubMed ID: 26770316
    [Abstract] [Full Text] [Related]

  • 14. [Mechanism of Jiawei Huangqin decoction for treating ulcerative colitis in mice: the role of STAT3/NF-kB/IL-6 pathway].
    Wang K, Miao Z, Dong Y, Ye B.
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Feb 29; 40(2):196-202. PubMed ID: 32376533
    [Abstract] [Full Text] [Related]

  • 15. [Effects of Dandelion polysaccharide on IL-6/STAT3 signaling pathway in ulcerative colitis rats].
    Wang Q, Bie YL, Wang D, Fan WT.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May 08; 33(5):422-425. PubMed ID: 29926586
    [Abstract] [Full Text] [Related]

  • 16. Expression of the signal transducer and activator of transcription factor 3 and Janus kinase 3 in colorectal carcinomas, colonic adenomas and ulcerative colitis.
    Shareef MM, Shamloula MM, Elfert AA, El-Sawaf M, Soliman HH.
    Arab J Gastroenterol; 2009 Mar 08; 10(1):25-32. PubMed ID: 24842133
    [Abstract] [Full Text] [Related]

  • 17. Pien Tze Huang ameliorates DSS‑induced colonic inflammation in a mouse colitis model through inhibition of the IL‑6/STAT3 pathway.
    Li L, Shen A, Chu J, Sferra TJ, Sankararaman S, Ke X, Chen Y, Peng J.
    Mol Med Rep; 2018 Jul 08; 18(1):1113-1119. PubMed ID: 29845215
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of microRNA-495 improves the intestinal mucosal barrier function by targeting STAT3 via inhibition of the JAK/STAT3 signaling pathway in a mouse model of ulcerative colitis.
    Chu XQ, Wang J, Chen GX, Zhang GQ, Zhang DY, Cai YY.
    Pathol Res Pract; 2018 Jan 08; 214(1):151-162. PubMed ID: 29129493
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
    Polytarchou C, Hommes DW, Palumbo T, Hatziapostolou M, Koutsioumpa M, Koukos G, van der Meulen-de Jong AE, Oikonomopoulos A, van Deen WK, Vorvis C, Serebrennikova OB, Birli E, Choi J, Chang L, Anton PA, Tsichlis PN, Pothoulakis C, Verspaget HW, Iliopoulos D.
    Gastroenterology; 2015 Oct 08; 149(4):981-92.e11. PubMed ID: 26055138
    [Abstract] [Full Text] [Related]

  • 20. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation.
    Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A.
    J Exp Med; 2001 Feb 19; 193(4):471-81. PubMed ID: 11181699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.